SCHEMBL1764462

SCHEMBL1764462

CCCCc1c(O)cccc1-c1cccc2[nH]nnc12.[Na]

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.36
HPGD P15428 4/20 0.36
HSD17B10 Q99714 4/20 0.36
ALDH1A1 P00352 4/20 0.36
SLC37A4 O43826 1/20 0.35
P2RX7 Q99572 1/20 0.35
GAA P10253 3/20 0.34
MGAM O43451 2/20 0.34
SI P14410 2/20 0.34
MGAM2 Q2M2H8 2/20 0.34
ELANE P08246 2/20 0.34
CTSG P08311 2/20 0.34
GCGR P47871 1/20 0.34
MAPK1 P28482 3/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
HTT P42858 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
TP53 P04637 1/20 0.32
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29984918 1.00 KDM4E (0.36) KDM4EHPGDHSD17B10ALDH1A1SLC37A4
SCHEMBL29682317 0.99 KDM4E (0.36) KDM4EHPGDHSD17B10ALDH1A1SLC37A4
SCHEMBL3651400 0.99 KDM4E (0.36) KDM4EHPGDHSD17B10ALDH1A1SLC37A4
SCHEMBL5420603 0.91 KDM4E (0.35) KDM4EHPGDHSD17B10ALDH1A1SLC37A4
SCHEMBL5411649 0.88 KDM4E (0.36) KDM4EHPGDHSD17B10ALDH1A1GAA
SCHEMBL8218688 0.82 MGAM (0.33) GAAMGAMSIMGAM2
SCHEMBL31268387 0.81 KDM4E (0.36) KDM4EHPGDHSD17B10ALDH1A1GAA
SCHEMBL31268386 0.81 KDM4E (0.36) KDM4EHPGDHSD17B10ALDH1A1GAA
SCHEMBL3434840 0.81 KDM4E (0.38) KDM4EHPGDHSD17B10ALDH1A1SLC37A4
SCHEMBL28557327 0.81 NPC1 (0.41) HPGDGAAMAPK1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2538938-B1 FUNGAL NAIL TREATMENT COMPOSITION LRC PRODUCTS (GB) 2019-04-24 EP claimed
EP-2205200-A2 HAIR CARE FORMULATIONS COMPRISING UV-ABSORBERS AND SILICONES BASF SE (DE) 2010-07-14 EP claimed
WO-2009043841-A2 HAIR CARE FORMULATIONS COMPRISING UV-ABSORBERS AND SILICONES BASF SE (DE) 2009-04-09 WO claimed
CN-121586704-A Adhesive photoprotective compounds and uses thereof 斯奇诺西维 2026-02-27 CN disclosed
US-20250177286-A1 COMPOSITIONS FOR SENSITIVE SKIN MARY KAY INC. 2025-06-05 US disclosed
US-12233154-B2 Compositions for sensitive skin MARY KAY INC (US) 2025-02-25 US disclosed
US-20240207170-A1 COMPOSITIONS FOR SENSITIVE SKIN ALLUSTRA TECHNOLOGIES LLC 2024-06-27 US disclosed
US-11865204-B2 Compositions for sensitive skin MARY KAY INC. (US) 2024-01-09 US disclosed
EP-3532020-B1 FEMININE HYGIENE PRODUCTS RB HEALTH US LLC (US) 2023-03-29 EP disclosed
US-11576880-B2 Feminine hygiene products RB HEALTH (US) LLC (US) 2023-02-14 US disclosed
US-20200367492-A1 TREATMENT COMPOSITIONS PROVIDING AN ANTIMICROBIAL BENEFIT RECKITT BENCKISER LLC (US) 2020-11-26 US disclosed
WO-2007031756-A1 FOAMING TOPICAL COMPOSITIONS RECKITT BENCKISER INC (US) 2007-03-22 WO disclosed
WO-2007031793-A2 IMPROVEMENTS IN OR RELATIMG TO COSMETIC COMPOSITIONS RECKITT BENCKISER (UK) LIMITED (GB) 2007-03-22 WO disclosed
US-7166137-B2 Methods, compositions, and kits for coloring hair REVLON CONSUMER PRODUCTS CORPORATION (US) 2007-01-23 US disclosed
WO-2006117516-A2 TOPICAL COMPOSITIONS RECKITT BENCKISER INC (US) 2006-11-09 WO disclosed
US-20050097684-A1 Methods, compositions, and kits for coloring hair MUFG BANK LTD. AS AGENT 2005-05-12 US disclosed
US-20050069517-A1 Hair conditioning compositions NEUTROGENA CORPORATION 2005-03-31 US disclosed
US-20050069516-A1 Hair conditioning products NEUTROGENA CORPORATION 2005-03-31 US disclosed
US-6669933-B2 For oxidatively coloring hair in twelve minutes or less REVLON CONSUMER PRODUCTS CORPORATION 2003-12-30 US disclosed
WO-2002089748-A2 METHOD AND COMPOSITIONS FOR COLORING HAIR REVLON CONSUMER PRODUCTS CORPORATION (US) 2002-11-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11576880-B2 Feminine hygiene products LDHA, TES, LDHB KDM4E 2322/4885HPGD 173/4885HSD17B10 434/4885
US-20200367492-A1 TREATMENT COMPOSITIONS PROVIDING AN ANTIMICROBIAL BENEFIT CUTA, DSG1, SGMS1 KDM4E 4779/4885HPGD 3694/4885HSD17B10 2229/4885
US-20050097684-A1 Methods, compositions, and kits for coloring hair COXFA4L2, COX5B, COX5A KDM4E 2790/4885HPGD 247/4885HSD17B10 455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.